Kering Taps Defense Advisers as Activist Bluebell Circles - Bloomberg
STOCKS TO WATCH: Vindi Banga backed for top job at GSK spin-off
Activist Investors Stand Up - Global Finance Magazine
Stock Spotlight: Haleon spinout boosts GSK but firm remains dependant on pipeline
GSK rejects three Unilever bids to buy consumer healthcare arm, says unit was fundamentally undervalued - Wikinews, the free news source
Another Hedge Fund Joins in Criticism of GlaxoSmithKline CEO - Barrons
After bruising year, GSK approaches consumer split in better health
UK Stock News: Elliott Management Builds Significant Stake in GSK: Source - Bloomberg
Activist Hedge Funds: Full Guide
Bluebell pressures Bayer to separate crop and pharma units
Emma Walmsley
GSK rejects $68 billion Unilever offer for consumer assets, Retail News, ET Retail
Punchy Bluebell an unlikely ally to US giant in Glaxo stand-off